Deerfield Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-300,000	Closed	-$11.3M	–	109
2020 Q2	$11.3M	Buy	+300,000	New	+$11.3M	0.33%	74